MHRA Approves Krazati: A Breakthrough Therapy for Advanced Non-Small Cell Lung Cancer
Green light from MHRA for Krazati (Adagrasib) – that targets NSCLC....
A wonderful serenity has taken possession of my entire soul, like these sweet mornings of spring which I enjoy with my whole heart. I am alone, and feel the charm of existence in this spot, which was created for the bliss of souls like mine.
Green light from MHRA for Krazati (Adagrasib) – that targets NSCLC....
Mobile stroke units (MSUs) have emerged as a game-changer in prehospital stroke...
AstraZeneca's new drug – Sipavibart, represents a significant step forward in...
In a stride toward advancing neonatal and paediatric care, Owen Mumford, a...
Restoring extinct species stands at the forefront of scientific innovation, and...